The global antacid market is projected to register significant growth during the forecast period. The increase in the prevalence of gastric diseases due to changing dietary habits is augmenting the development of a more enhanced gastric solution for acidity and heartburns. Antacids are the class of drugs which reduces gastric acidity which occurs from the increase in pH level in the stomach and duodenum. The various factors leading to gastric diseases are an unhealthy diet, lack of proper sleep, and lack of physical activities. This has resulted in the accelerated market share of antacids. The advancement of e-commerce industry coupled with the consumer preference for online medication is significantly propelling the growth of the global antacid market. Moreover, the population with Gastroesophageal reflux disease, or GERD, has increased significantly resulting in the increasing demand for antacids across the globe.

The antacid market is segmented on the basis of drug class and formulation type. Based on drug class, the market is segmented into the proton pump inhibitor, H2 antagonist, and acid neutralizers. Among these drug classes, the acid neutralizers segment is expected to register significant growth in the market during the forecast period, as it provides rapid relief against heartburns and acidity. Moreover, the availability of acid neutralizers in various flavors and formulations tends to drive the market share of acid neutralizers. Based on the formulation type, the market is segmented into tablet, liquid, and powder. The liquid segment is expected to show prominent growth in the market during the forecast period, as it is widely preferred solution among infants and geriatric populations for acidity and heartburns due to ease of intake and palatable taste.

Geographically, the global antacid market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. Asia-Pacific is expected to register considerable growth in the market during the forecast period. This is owing to rising consumer awareness, continuous investment by market players and growing disposable income have increased the market share of antacids. Moreover, the presence of key players such as GlaxoSmithKline PLC, has increased the availability of effective treatment methods that fosters the growth of the antacid market in the region.

The major players operating in the global antacid market are GlaxoSmithKline PLC, Abbott Laboratories, Reckitt Benckiser Group PLC, Bayer AG, Sanofi SA, Pfizer Inc., and The Procter & Gamble Co., among others. These companies are adopting several strategies, such as merger and acquisitions, product launches, geographical expansion and collaboration, and partnership to expand market share across the globe. For instance, in May 2018, GlaxoSmithKline PLC has launched sugar-free TUMS Chewy Bites for consumers looking to reduce daily sugar intake. These chew bites offer relief against heartburns and gas. Through continuous expansion in its product portfolio, the company is looking to hold the dominant share in the global antacid market.

Research Methodology

The market study of the global antacid market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for healthcare and pharmaceuticals providers for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Antacid Market Research and Analysis by Drug Class
2. Global Antacid Market Research and Analysis by Formulation Type

The Report Covers:

• Comprehensive research methodology of the global antacid market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global antacid market.
• Insights about market determinants which are stimulating the global antacid market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.